SAFETY ASSESSMENT OF DOSE-ESCALATED 225AC-PSMA-617 RADIOLIGAND THERAPY IN PATIENTS WITH ADVANCED METASTATIC CASTRATION-RESISTANT PROSTATE CANCER FOLLOWING STANDARD TREATMENT FAILURE ArticleKochetova Tatiana Yu, Krylov V.V., Stepanenko V.F., Musabaev Iskander E., Ivanov Sergei A., Kaprin Andrey D.Voprosy Onkologii. Том 71. 2025. С. 1144-1151
